Page last updated: 2024-08-16

temozolomide and pf-06687252

temozolomide has been researched along with pf-06687252 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
He, Y; Miller, DD; Pfeffer, LM; Sacher, JR; Sims, MM; Wang, Y; Yang, C	1

Other Studies

1 other study(ies) available for temozolomide and pf-06687252

Article	Year
Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorganic & medicinal chemistry, 2022, 01-01, Volume: 53 Topics: Animals; Antineoplastic Agents, Alkylating; Azabicyclo Compounds; Cell Death; Cell Proliferation; DNA Helicases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Glioblastoma; Humans; Mice; Mice, Congenic; Mice, Inbred NOD; Molecular Structure; Neoplasms, Experimental; Nuclear Proteins; Pyridines; Structure-Activity Relationship; Temozolomide; Transcription Factors	2022

Article

Year

Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.

Bioorganic & medicinal chemistry, 2022, 01-01, Volume: 53

Topics: Animals; Antineoplastic Agents, Alkylating; Azabicyclo Compounds; Cell Death; Cell Proliferation; DNA Helicases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Glioblastoma; Humans; Mice; Mice, Congenic; Mice, Inbred NOD; Molecular Structure; Neoplasms, Experimental; Nuclear Proteins; Pyridines; Structure-Activity Relationship; Temozolomide; Transcription Factors

2022